Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?
- PMID: 18775115
- DOI: 10.1007/s11906-008-0071-5
Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?
Comment on
-
Telmisartan, ramipril, or both in patients at high risk for vascular events.N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Clinical Trial.